Advertisement
Advertisement

IVVD

IVVD logo

Invivyd, Inc. Common Stock

1.47
USD
Sponsored
-0.02
-1.34%
May 13, 15:54 UTC -4
Closed
exchange

Pre-Market

1.49

+0.02
+1.02%

Invivyd, Inc. Common Stock Profile

About

INVIVYD INC. is a biopharmaceutical company. It involved in developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. INVIVYD INC., formerly known as Adagio Therapeutics, is based in WALTHAM, Mass.

Info & Links

CEO

William Duke, Jr.

Headquarters

1601 TRAPELO ROAD,SUITE 178
WALTHAM, MA 02451, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://invivyd.com

Auditor

PricewaterhouseCoopers LLP

Share holders

7

Employees

122

Invivyd, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

419.96M

Enterprise Value

193.27M

Enterprise Value/EBITDA(ttm)

-3.62

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

9.42

Price to Book(mrq)

1.72

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

92.97%

Operating Margin(ttm)

-98.25%

Profit Margin(ttm)

-103.14%

Return on Equity(ttm)

-48.65%

Return on Invested Capital(ttm)

-80.18%

Return on Assets(ttm)

-34.48%

Income Statement

Revenue(ttm)

53.43M

Revenue Per Share(ttm)

0.19

Gross Profit(ttm)

49.68M

EBITDA(ttm)3

-53.45M

Net Income Available to Common(ttm)

-52.49M

Diluted EPS(ttm)

-0.32

Share Statistics

Beta (5Y Monthly)

0.73

52-Week Change

70.75%

S&P 500 52-Week Change

26.33%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

282.59M

Dividend Yield

0.00%

Float4

210.97M

% Held by Insiders

25.40%

% Held by Institutions

70.36%

Balance Sheet

Total Cash(mrq)

226.69M

Total Cash Per Share(mrq)

0.80

Total Debt(mrq)

0.00

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

7.24%

Quick Ratio(mrq)

7.24%

Book Value Per Share(mrq)

0.86

Cash Flow

Operating Cash Flow Per Share(ytd)

-0.34

Free Cash Flow(ytd)

-58.29M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement